Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 06, 2026 07:00 ET | Source: VERAXA Biotech GmbH

VERAXA Biotech Provides Business Update and Further Details on Partnering Strategy and Development Timelines

VERAXA Biotech AG (NASDAQ: VRXA; “VERAXA”) today provided a company and pipeline update.
July 02, 2026 07:00 ET | Source: VERAXA Biotech GmbH

VERAXA Biotech Initiates Cell Line Development with ATUM to Advance its Lead BiTAC®-TCE Program

VERAXA Biotech announces further progress with lead BiTAC® T-cell engager (BiTAC-TCE) program, initiates cell line development with ATUM.